Journal
FUTURE MICROBIOLOGY
Volume 2, Issue 6, Pages 655-666Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/17460913.2.6.655
Keywords
antibiotic resistance; Grain-positive pathogens; immunotherapy; MRSA; new targets; novel antibacrerials; Stapbylococcus aureus
Categories
Ask authors/readers for more resources
Multiple resistant staphylococci that cause significant morbidity and mortality are the leading cause of nosocomial infections. Meanwhile, methicillin-resistant Staphylococcus aureus (MRSA) also spreads in the community, where highly virulent strains infect children and young adults who have no predisposing risk factors. Although some treatment options remain, the search for new antibacterial targets and lead compounds is urgently required to ensure that staphylococcal infections can be effectively treated in the future. Promising targets for new antibacterials are gene products that are involved in essential cell functions. In addition to antibacterials, active and passive immunization strategies are being developed that target surface components of staphylococci such as cell wall-linked adhesins, teichoic acids and capsule or immunodominant antigens.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available